CoagulationDisorders near Sleepy Hollow, NY

Biography: Dr. Chris Hackett received his BS in Biological Sciences from Stanford University in 2000. After doing biomedical research in industry and academia, he then pursued graduate studies in cancer genomics at the University of California, San Francisco, where he earned his PhD in 2010. Seeking to become a physician-scientist, he then earned his medical degree (MD) from the University of Minnesota in 2014. He then completed his Internal Medicine Residency at NewYork-Presbyterian/Weill Cornell Medical Center, followed by a fellowship in Medical Oncology at Memorial Sloan Kettering Cancer Center (MSK), where he focused on solid tumor oncology in the clinic and carried out laboratory research to design T cell therapies for cancer. Following fellowship, Dr. Hackett was an attending on the Cellular Therapeutics Service at MSK, where he focused on treating patients with CAR T cells, Tumor Infiltrating Lymphocytes (TIL) and other cell therapies. In 2023, he joined the Bone Marrow Transplant Service at Weill Cornell Medicine and NewYork-Presbyterian Hospital, where he continues to both treat patients with cellular therapies and conduct research to develop new cell therapies for solid tumors.

Biography: Caitlin Gribbin, MD, is an Instructor in Medicine within the Division of Hematology and Oncology at Weill Cornell Medical Center. After earning her B.A. from Cornell University, Dr. Gribbin received her Medical Degree as well as Masters in Science from Weill Cornell Medical College. She completed her Internship and Residency as well as subsequent Fellowship training in Hematology and Oncology within the Medical Research Track at Weill Cornell Medicine/NewYork-Presbyterian Hospital. As a faculty member at Weill Cornell, Dr. Gribbin specializes in treating patients with lymphoma using cellular therapies, including chimeric antigen receptor (CAR) T cell therapy. She is simultaneously focused on leading clinical and translational research studies aimed at improving lymphoma treatments by bringing novel scientific discoveries to patients. Dr. Gribbin has co-authored numerous publications and presentations at national and international meetings and has received several research grants, including the American Society of Clinical Oncology (ASCO) Young Investigator Award, the Lymphoma Research Foundation (LRF) Scientific Research Mentoring Program Award, and the Burroughs Wellcome Fund Award.

Biography: Dr. Laura S. Munoz Arcos is an Assistant Professor of Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and an Assistant Attending Physician at NewYork-Presbyterian Hospital.Dr. Munoz Arcos earned her medical degree from Universidad del Valle in Colombia, her home country. She then completed an internal medicine residency at Montefiore Medical Center/Albert Einstein College of Medicine in the Bronx, NY, followed by a Hematology and Oncology fellowship at Weill Cornell Medicine/NewYork-Presbyterian Hospital, where she served as Chief Fellow in her final year. During her fellowship, Dr. Munoz Arcos gained extensive clinical experience in treating all types of breast cancer while conducting translational research on liquid biopsy in breast cancer at Dr. Massimo Cristofanilli's laboratory. Her research focuses on identifying predictors of response to therapy in hormone receptor-sensitive metastatic breast cancer. In recognition of her work, she received the 2023 Conquer Cancer American Society of Clinical Oncology (ASCO) Young Investigator Award, a prestigious honor granted to only 100 recipients annually. Following the completion of her fellowship, Dr. Munoz Arcos joined the Division of Hematology and Medical Oncology as a faculty member, where she is focused on the treatment of breast cancer.

Biography: Dr. Bobak Parang completed his undergraduate studies at the University of Pennsylvania, where he majored in Biology. He subsequently earned his MD and PhD from Vanderbilt University School of Medicine. He then joined the Weill Cornell Medicine Physician Scientist Training Program where he completed his internal medicine residency and hematology / medical oncology fellowship. During his last year of fellowship, Dr. Parang served as Chief Fellow. As a member of the Weill Cornell Medicine faculty, Dr. Parang is a physician-scientist whose clinical and research interests are focused on lung cancer drug resistance and metastases.